Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

[1] Goldstraw P(2007)The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 706-714

[2] Crowley J(2014)Prognostic and predictive biomarkers in lung cancer. A review Virchows Arch 464 347-358

[3] Chansky K(2013)Clinical significance of the tumor microenvironment in non-small cell lung cancer Ann Transl Med 1 20-230

[4] Giroux DJ(2013)The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 88 218-2016

[5] Groome PA(2014)Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis J Natl Cancer Inst 106 124-869

[6] Rami-Porta R(2012)Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy J Cancer Res Clin Oncol 138 2009-428

[7] Thunnissen E(2012)Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer Clin Transl Oncol 14 864-1958

[8] van der Oord K(2009)Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 425-3538

[9] den Bakker M(2009)Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 Eur J Cancer 45 1950-479

[10] Shimizu K(2012)Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer Anticancer Res 32 3535-1005

[1] Goldstraw P(2007)The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 706-714

[2] Crowley J(2014)Prognostic and predictive biomarkers in lung cancer. A review Virchows Arch 464 347-358

[3] Chansky K(2013)Clinical significance of the tumor microenvironment in non-small cell lung cancer Ann Transl Med 1 20-230

[4] Giroux DJ(2013)The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 88 218-2016

[5] Groome PA(2014)Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis J Natl Cancer Inst 106 124-869

[6] Rami-Porta R(2012)Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy J Cancer Res Clin Oncol 138 2009-428

[7] Thunnissen E(2012)Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer Clin Transl Oncol 14 864-1958

[8] van der Oord K(2009)Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 425-3538

[9] den Bakker M(2009)Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 Eur J Cancer 45 1950-479

[10] Shimizu K(2012)Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer Anticancer Res 32 3535-1005